Published in

Springer, International Journal of Clinical Pharmacy, 4(40), p. 852-861, 2018

DOI: 10.1007/s11096-018-0665-1

Links

Tools

Export citation

Search in Google Scholar

Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO